Amalgamated Bank Tg Therapeutics, Inc. Transaction History

Amalgamated Bank

  • $12.1 Billion
  • Q3 2024

A detailed history of Amalgamated Bank transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 39,528 shares of TGTX stock, worth $1.17 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
39,528
Previous 4,868 712.0%
Holding current value
$1.17 Million
Previous $87,000 963.22%
% of portfolio
0.01%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024
BUY
$17.21 - $25.28 $596,498 - $876,204
34,660 Added 712.0%
39,528 $925,000
Q2 2024

Aug 12, 2024
BUY
$13.32 - $19.19 $4,129 - $5,948
310 Added 6.8%
4,868 $87,000
Q1 2024

Apr 23, 2024
SELL
$13.02 - $21.3 $198,437 - $324,633
-15,241 Reduced 76.98%
4,558 $69,000
Q4 2023

Feb 06, 2024
SELL
$6.68 - $18.81 $6,118 - $17,229
-916 Reduced 4.42%
19,799 $338,000
Q2 2023

Aug 11, 2023
BUY
$15.48 - $35.0 $28,374 - $64,155
1,833 Added 9.71%
20,715 $514,000
Q1 2023

May 02, 2023
SELL
$10.23 - $19.34 $23,692 - $44,791
-2,316 Reduced 10.93%
18,882 $284,000
Q3 2022

Nov 09, 2022
BUY
$4.57 - $8.4 $1,553 - $2,856
340 Added 1.63%
21,198 $125,000
Q2 2022

Aug 15, 2022
SELL
$3.74 - $10.66 $979 - $2,792
-262 Reduced 1.24%
20,858 $89,000
Q1 2022

Jun 30, 2022
SELL
$7.81 - $20.45 $12,511 - $32,760
-1,602 Reduced 7.05%
21,120 $201,000
Q4 2021

Feb 15, 2022
SELL
$15.2 - $35.51 $1,231 - $2,876
-81 Reduced 0.36%
22,722 $432,000
Q3 2021

Oct 29, 2021
SELL
$21.78 - $40.45 $30,557 - $56,751
-1,403 Reduced 5.8%
22,803 $759,000
Q2 2021

Aug 16, 2021
BUY
$32.5 - $48.96 $259,415 - $390,798
7,982 Added 49.2%
24,206 $939,000
Q1 2021

May 13, 2021
SELL
$41.61 - $54.3 $25,465 - $33,231
-612 Reduced 3.64%
16,224 $782,000
Q4 2020

Feb 12, 2021
BUY
$25.27 - $54.9 $17,512 - $38,045
693 Added 4.29%
16,836 $875,000
Q3 2020

Oct 30, 2020
BUY
$18.49 - $27.24 $31,839 - $46,907
1,722 Added 11.94%
16,143 $432,000
Q2 2020

Aug 10, 2020
SELL
$8.9 - $21.84 $1,290 - $3,166
-145 Reduced 1.0%
14,421 $281,000
Q1 2020

May 13, 2020
SELL
$7.14 - $15.99 $5,205 - $11,656
-729 Reduced 4.77%
14,566 $143,000
Q4 2019

Feb 13, 2020
BUY
$5.1 - $11.2 $8,328 - $18,289
1,633 Added 11.95%
15,295 $170,000
Q3 2019

Nov 13, 2019
SELL
$5.38 - $8.99 $575 - $961
-107 Reduced 0.78%
13,662 $77,000
Q2 2019

Aug 14, 2019
BUY
$6.27 - $8.65 $86,331 - $119,101
13,769 New
13,769 $119,000

Others Institutions Holding TGTX

# of Institutions
338
Shares Held
88.3M
Call Options Held
2.35M
Put Options Held
1.7M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.29B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email